Kato K - Search Results

1

FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancer.

Hasegawa H, Taniguchi H, Nakamura Y, Kato T, Fujii S, Ebi H, Shiozawa M, Yuki S, Masuishi T, Kato K, Izawa N, Moriwaki T, Oki E, Kagawa Y, Denda T, Nishina T, Tsuji A, Hara H, Esaki T, Nishida T, Kawakami H, Sakamoto Y, Miki I, Okamoto W, Yamazaki K, Yoshino T. Hasegawa H, et al. Among authors: kato t, kato k. Cancer Sci. 2021 Jan;112(1):314-322. doi: 10.1111/cas.14693. Epub 2020 Nov 20. Cancer Sci. 2021. PMID: 33075166 Free PMC article.

2

Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer.

Qin B, Kato K, Mitsugi K, Nakamura M, Tanaka R, Baba E, Ariyama H, Kuroiwa T, Harada M, Nakano S. Qin B, et al. Among authors: kato k. Cancer Chemother Pharmacol. 2006 Jan;57(1):114-9. doi: 10.1007/s00280-005-0021-8. Epub 2005 Nov 5. Cancer Chemother Pharmacol. 2006. PMID: 16001177

3

Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples.

Yamada Y, Arao T, Gotoda T, Taniguchi H, Oda I, Shirao K, Shimada Y, Hamaguchi T, Kato K, Hamano T, Koizumi F, Tamura T, Saito D, Shimoda T, Saka M, Fukagawa T, Katai H, Sano T, Sasako M, Nishio K. Yamada Y, et al. Among authors: kato k. Cancer Sci. 2008 Nov;99(11):2193-9. doi: 10.1111/j.1349-7006.2008.00935.x. Epub 2008 Jan 11. Cancer Sci. 2008. PMID: 18957060 Free article. Clinical Trial.

4

Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.

Takahari D, Yamada Y, Okita NT, Honda T, Hirashima Y, Matsubara J, Takashima A, Kato K, Hamaguchi T, Shirao K, Shimada Y, Shimoda T. Takahari D, et al. Among authors: kato k. Oncology. 2009;76(1):42-8. doi: 10.1159/000178164. Epub 2008 Nov 26. Oncology. 2009. PMID: 19033715

5

Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer.

Hirashima Y, Yamada Y, Matsubara J, Takahari D, Okita N, Takashima A, Kato K, Hamaguchi T, Shirao K, Shimada Y, Taniguchi H, Shimoda T. Hirashima Y, et al. Among authors: kato k. Cancer Sci. 2009 Feb;100(2):310-5. doi: 10.1111/j.1349-7006.2008.01020.x. Cancer Sci. 2009. PMID: 19068081 Free article.

6

A phase I escalating single-dose and weekly fixed-dose study of cetuximab pharmacokinetics in Japanese patients with solid tumors.

Shirao K, Yoshino T, Boku N, Kato K, Hamaguchi T, Yasui H, Yamamoto N, Tanigawara Y, Nolting A, Yoshino S. Shirao K, et al. Among authors: kato k. Cancer Chemother Pharmacol. 2009 Aug;64(3):557-64. doi: 10.1007/s00280-008-0904-6. Epub 2009 Jan 24. Cancer Chemother Pharmacol. 2009. PMID: 19169687 Clinical Trial.

7

Phase I study of the sequential administration of S-1 and cisplatin for metastatic gastric cancer.

Baba E, Fujishima H, Kusaba H, Esaki T, Ariyama H, Kato K, Tanaka R, Mitsugi K, Shibata Y, Harada M, Nakano S. Baba E, et al. Among authors: kato k. Anticancer Res. 2009 May;29(5):1727-32. Anticancer Res. 2009. PMID: 19443394 Free article. Clinical Trial.

8

Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer.

Nakajima TE, Yamada Y, Hamano T, Furuta K, Matsuda T, Fujita S, Kato K, Hamaguchi T, Shimada Y. Nakajima TE, et al. Among authors: kato k. Cancer Sci. 2010 May;101(5):1286-91. doi: 10.1111/j.1349-7006.2010.01518.x. Epub 2010 Jan 31. Cancer Sci. 2010. PMID: 20331631 Free article.

9

Plasma concentrations of VCAM-1 and PAI-1: a predictive biomarker for post-operative recurrence in colorectal cancer.

Yamada Y, Arao T, Matsumoto K, Gupta V, Tan W, Fedynyshyn J, Nakajima TE, Shimada Y, Hamaguchi T, Kato K, Taniguchi H, Saito Y, Matsuda T, Moriya Y, Akasu T, Fujita S, Yamamoto S, Nishio K. Yamada Y, et al. Among authors: kato k. Cancer Sci. 2010 Aug;101(8):1886-90. doi: 10.1111/j.1349-7006.2010.01595.x. Epub 2010 Apr 21. Cancer Sci. 2010. PMID: 20491774 Free article.

10

A multicenter phase-II study of 5-FU, leucovorin and oxaliplatin (FOLFOX6) in patients with pretreated metastatic colorectal cancer.

Kato K, Inaba Y, Tsuji Y, Esaki T, Yoshioka A, Mizunuma N, Mizuno T, Kusaba H, Fujii H, Muro K, Shimada Y, Shirao K. Kato K, et al. Jpn J Clin Oncol. 2011 Jan;41(1):63-8. doi: 10.1093/jjco/hyq158. Epub 2010 Sep 6. Jpn J Clin Oncol. 2011. PMID: 20819832 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,690 results

Search Page